CLINICAL_TRIALS trial_result · 2015-11-20

Clinical Trial Update: Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma [Phase 2]

A phase 2 trial evaluating AIN457 for uncontrolled asthma was terminated, with results on safety, tolerability, and efficacy posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2015-11-20